Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Acquisitions & Divestments: 2017-2021

Historic Change in Acquisitions & Divestments for Arcus Biosciences (RCUS) over the last 5 years, with Dec 2021 value amounting to $690.1 million.

  • Arcus Biosciences' Change in Acquisitions & Divestments rose 70.93% to $228.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $608.8 million, marking a year-over-year decrease of 18.19%. This contributed to the annual value of $690.1 million for FY2021, which is 124.53% up from last year.
  • According to the latest figures from FY2021, Arcus Biosciences' Change in Acquisitions & Divestments is $690.1 million, which was up 124.53% from $307.3 million recorded in FY2020.
  • Arcus Biosciences' 5-year Change in Acquisitions & Divestments high stood at $690.1 million for FY2021, and its period low was $53.3 million during FY2017.
  • For the 3-year period, Arcus Biosciences' Change in Acquisitions & Divestments averaged around $435.4 million, with its median value being $308.9 million (2019).
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 185.05% in 2018, then declined by 0.50% in 2020.
  • Over the past 5 years, Arcus Biosciences' Change in Acquisitions & Divestments (Yearly) stood at $53.3 million in 2017, then skyrocketed by 185.05% to $151.9 million in 2018, then soared by 103.41% to $308.9 million in 2019, then dropped by 0.50% to $307.3 million in 2020, then soared by 124.53% to $690.1 million in 2021.